While Western pharmaceutical manufacturers are taking the lead in developing vaccines for the new coronavirus, the Liberal Democratic Party has set up a countermeasure team to enhance the international competitiveness of the domestic pharmaceutical industry, and is proceeding with verification of research and development and regulatory approval. , I will summarize the recommendations.
Regarding the vaccine for the new coronavirus, Western pharmaceutical manufacturers such as Pfizer in the United States have taken the lead in development, and China and Russia have also developed it in their own country and supplied it to each country, so from the perspective of security, it is also domestic. There are voices concerned about the delay in the development of.
Under these circumstances, the Liberal Democratic Party has set up a countermeasure team chaired by former Deputy Minister of Health, Labor and Welfare Hashimoto to consider measures to enhance the international competitiveness of the domestic pharmaceutical industry, not limited to vaccine development.
While it has been pointed out that the cost of drug development is soaring, the scale of domestic companies is smaller and the cost is limited compared to Western pharmaceutical manufacturers, so it is possible to develop highly profitable drugs with efficient investment. Is an issue.
For this reason, the countermeasure team will broadly examine issues for strategically advancing drug research and development, human resource development, regulatory approvals, drug prices, etc., and compile recommendations to the government.